NeuroSense Therapeutics Ltd. (NASDAQ:NRSN – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 176,100 shares, an increase of 78.8% from the May 15th total of 98,500 shares. Based on an average daily volume of 3,790,000 shares, the short-interest ratio is […]